Biodel Announces Removal of Partial Clinical Hold for BIOD-531 and Plans for Potential Expansion of Target Patient Population
October 12, 2015 at 07:01 AM EDT
Biodel Inc. (NASDAQ: BIOD) today announced that the United States Food and Drug Administration (FDA) has removed the partial clinical ...